针对 Mycobacterium 结核病的铁清理工具:最近关于 siderophores 抑制剂的最新更新
Gautam Kumar1, Patil Amruta Adhikrao1
1Department of Natural Products, Chemical Sciences, National Institute of Pharmaceutical Education and Research-Hyderabad (NIPER-Hyderabad) Balanagar Hyderabad 500037 India gautam.kumar2@niperhyd.ac.in.
由于耐药性,结核病 (TB) 是全球主要的健康威胁. 这项研究探讨了Mycobacterium tuberculosis (M.tb) 消耗铁的机制和抑制剂作为潜在的新型抗结核药物.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 结核病 (TB) 仍然是全球主要的死亡原因,由艾滋病毒联合感染加剧.
- 对现有的抗结核药物 (MDR,XDR,TDR) 的耐药性增加需要新的治疗策略.
- 结核菌菌 (M.tb) 依赖宿主铁来生存和生长,采用特定的清理机制.
研究的目的:
- 为了提供M.tb的铁工具的概述.
- 总结一下最近发现的M.tb铁消耗途径的抑制剂.
- 突出这些抑制剂作为新型抗结核病药物的潜力.
主要方法:
- 关于M.tb铁获取机制的文献综述.
- 针对MbtA和MbtI蛋白的已识别的抑制剂的概述.
- 对这些抑制剂的治疗潜力的分析.
主要成果:
- M.tb利用复杂的策略从宿主细胞中获取铁.
- 已经确定了针对MbtA和MbtI的抑制剂.
- 这些抑制剂在破坏M.tb的铁获取方面表现有前途.
结论:
- 针对M.tb的铁清理机制,为开发新的抗结核药物提供了一个可行的策略.
- MbtA和MbtI抑制剂是新型抗结核病疗法的有希望的候选者.
- 进一步开发这些抑制剂可以对抗耐药结核病菌株.
更多相关视频
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
相关概念视频
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
